We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+13.86%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$450M
AUM Growth
+$44.2M
Cap. Flow
+$6.33M
Cap. Flow %
1.41%
Top 10 Hldgs %
82.16%
Holding
81
New
7
Increased
6
Reduced
2
Closed
4

Top Buys

Rank Stock Value
1
BLUE
bluebird bio
BLUE
+$4.88M
2
CUE icon
Cue Biopharma
CUE
+$2.38M
3
PROF
Profound Medical
PROF
+$1.27M
4
MDXH icon
MDxHealth
MDXH
+$1.26M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.1M

Top Sells

Rank Stock Value
1
DRRX
DURECT Corp
DRRX
+$6.57M
2
YEXT icon
Yext
YEXT
+$274K
3
EQRX
EQRx, Inc. Common Stock
EQRX
+$11.1K
4
EQRXW
EQRx, Inc. Warrant
EQRXW
+$8.02K
5
LLYVK icon
Liberty Live Group Series C
LLYVK
+$68

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 20.98%
2 Miscellaneous 20.63%
3 Healthcare 20.15%
4 Industrials 14.66%
5 Materials 10.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BC icon
1
Brunswick
BC
$4.97B
$94.4M 20.98%
975,636
– –
GLD icon
2
SPDR Gold Trust
GLD
$149B
$90.8M 20.18%
475,000
– –
LIN icon
3
Linde
LIN
$226B
$47.9M 10.64%
116,564
– –
INVE icon
4
Identive
INVE
$66.9M
$23.8M 5.28%
2,884,495
– –
FNA
5
DELISTED
Paragon 28, Inc.
FNA
$21.9M 4.87%
1,763,339
– –
IVAC
6
DELISTED
Intevac Inc
IVAC
$21.8M 4.84%
5,039,023
– –
MRNS
7
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$20.4M 4.52%
1,872,463
– –
SPGI icon
8
S&P Global
SPGI
$131B
$17.6M 3.92%
40,000
– –
GPGI
9
GPGI Inc
GPGI
$3.84B
$16.2M 3.6%
3,609,050
+9,752
+0.3% +$45.5K
MDXH icon
10
MDxHealth
MDXH
$68.8M
$15M 3.34%
3,878,333
+420,000
+12% +$1.26M
BX icon
11
Blackstone
BX
$107B
$10.5M 2.33%
80,000
– –
INSM icon
12
Insmed
INSM
$25.9B
$10.1M 2.24%
325,000
– –
OPTN
13
DELISTED
OptiNose
OPTN
$5.22M 1.16%
269,675
– –
JPM icon
14
JPMorgan Chase
JPM
$951B
$5.1M 1.13%
30,000
– –
AXP icon
15
American Express
AXP
$225B
$4.68M 1.04%
25,000
– –
CUE icon
16
Cue Biopharma
CUE
$203M
$4.63M 1.03%
58,501
+33,333
+132% +$2.38M
IDN icon
17
Intellicheck
IDN
$57.6M
$3.94M 0.88%
2,073,583
– –
DUOT icon
18
Duos Technologies
DUOT
$294M
$3.72M 0.83%
1,283,162
– –
PROK icon
19
ProKidney
PROK
$382M
$3.56M 0.79%
2,000,000
– –
BLUE
20
DELISTED
bluebird bio
BLUE
$3.45M 0.77%
125,000
+80,000
+178% +$4.88M
TV icon
21
Televisa
TV
$1.45B
$3.34M 0.74%
1,000,000
– –
MIST icon
22
Milestone Pharmaceuticals
MIST
$144M
$2.21M 0.49%
1,326,085
– –
LIQT icon
23
LiqTech
LIQT
$18.8M
$1.9M 0.42%
557,110
+136
+0% +$485
BRFH icon
24
Barfresh Food Group
BRFH
$20.4M
$1.83M 0.41%
1,153,915
+353,628
+44% +$599K
LSXMK
25
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$1.59M 0.35%
55,216
– –
1
2 3 4

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $559M AUM 21.55% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return

Bleichroeder LP's Q4 2023 Portfolio in Review

As of Q4 2023, Bleichroeder LP held 81 positions worth $450M, up 11% from $406M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Bleichroeder LP's Q4 2023 filing shows 7 new, 6 increased, 2 reduced and 4 closed positions. Its largest new stake was Profound Medical: 133,333 shares worth $1.13M. The largest sale was DURECT Corp, an estimated $6.57M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.

  • Bleichroeder LP's largest Q4 2023 buy was Profound Medical: 133,333 shares worth $1.13M.
  • Bleichroeder LP added most to bluebird bio in Q4 2023, an estimated $4.88M increase.
  • Bleichroeder LP's biggest Q4 2023 reduction was Liberty Live Group Series C, cutting an estimated $68.
  • Bleichroeder LP fully exited DURECT Corp in Q4 2023, selling an estimated $6.57M.
  • Bleichroeder LP's ten largest holdings make up 82% of its $450M portfolio in Q4 2023.
  • Bleichroeder LP opened 7 new positions and closed 4 in Q4 2023.
  • Bleichroeder LP's portfolio value rose 11% quarter-over-quarter to $450M.

Based on Bleichroeder LP's 13F filing for Q4 2023, filed 12 Feb 2024.